What is Maple syrup urine disease

Maple syrup urine disease (MSUD) is a rare, inherited metabolic disorder characterized by the body's inability to break down specific amino acids—leucine, isoleucine, and valine—leading to a dangerous buildup of these substances and their toxic byproducts. If left untreated, this accumulation can cause severe neurological damage and metabolic crisis, often identifiable by a sweet, maple syrup-like odor in the urine and earwax.

What causes Maple syrup urine disease?

Maple syrup urine disease is caused by mutations in the genes that provide instructions for making the branched-chain alpha-ketoacid dehydrogenase (BCKDH) complex. This enzyme complex is essential for breaking down the branched-chain amino acids (BCAAs) found in protein-rich foods. When this process is blocked, these amino acids and their corresponding alpha-keto acids build up in the blood and urine. This accumulation is toxic to the brain, and if not managed, can lead to brain swelling, intellectual disability, and life-threatening complications. Because it is a genetic condition, it is passed down from parents to children in an autosomal recessive pattern.

What are the different types of Maple syrup urine disease?

The severity of Maple syrup urine disease varies based on the amount of residual enzyme activity the body can still perform. The clinical classifications include:

• Classic MSUD: The most severe and common form. Infants typically show symptoms within the first few days of life and have less than 2% of normal enzyme activity.


• Intermediate MSUD: Individuals have a higher level of enzyme activity (3% to 30%) and may show symptoms later in childhood.


• Intermittent MSUD: These individuals have enough enzyme activity to remain healthy under normal conditions but experience metabolic crises during periods of stress, illness, or high protein intake.


• Thiamine-responsive MSUD: A rare variant where symptoms significantly improve with high doses of thiamine (Vitamin B1), which helps boost residual enzyme function.

How common is Maple syrup urine disease and who is affected?

On a global scale, the incidence of Maple syrup urine disease is estimated at approximately 1 in 185,000 live births. However, the prevalence varies significantly by population; it is notably more common in the Old Order Mennonite population, where the incidence is roughly 1 in 176. Because the condition is autosomal recessive, it affects males and females equally, and it is usually diagnosed in the newborn period through state-mandated newborn screening programs.

What differentiates Maple syrup urine disease from other metabolic disorders?

While many metabolic disorders cause developmental delays or failure to thrive, Maple syrup urine disease is uniquely distinguished by the distinct, sweet scent of maple syrup in the infant’s urine and earwax. Unlike some other metabolic conditions that manifest later, the classic form of this disease requires immediate intervention shortly after birth to prevent irreversible neurological damage. At DiseaseMaps.org, 82 people with Maple syrup urine disease have joined our community, sharing their experiences to help others navigate the complexities of this diagnosis.

Next steps

• Consult with a metabolic specialist or geneticist immediately if you suspect a diagnosis or have received positive newborn screening results.


• Work with a specialized metabolic dietitian to manage protein intake, which is the cornerstone of managing Maple syrup urine disease.


• Connect with the DiseaseMaps.org community to share experiences and find support from others living with the condition.


• Request a referral to a metabolic center that has experience managing patients with rare amino acid disorders.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Maple syrup urine disease.


• Orphanet: Rare disease database entry for Maple syrup urine disease.


• OMIM (Online Mendelian Inheritance in Man): Entry #248600 (MSUD).


• MSUD Family Support Group: Educational resources and patient advocacy.